About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘blood (journal) retractions’ Category

A year after ORI report, hematology journal retracts faked paper

with 4 comments

bloodA year after an ORI report discredited the work of former University of Washington in Seattle researcher Andrew Aprikyan, one of the papers named in the report has finally been retracted.

Here’s the notice for “Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia”:  Read the rest of this entry »

About these ads

Written by Cat Ferguson

August 6, 2014 at 9:30 am

Journal retracts stem cell study despite objections of most authors

with one comment

Gerold Feuer in 2008, via Upstate

Gerold Feuer in 2008, via Upstate

The journal Blood has retracted a 2010 paper over the objections of most of its authors, two of whom were found by their university to have used “fraudulent methods” to obtain the data.

We first reported on the case of Gerold Feuer last fall. The State University of New York (SUNY) Upstate Medical Center in Syracuse fired Feuer in 2010 after determining that he had misused state funds to enrich a company he had founded, HuMurine. A court agreed with many of the university’s claims, but ordered his reinstatement in 2012.

Meanwhile, as we noted last fall: Read the rest of this entry »

Contaminated cells force retraction of Blood paper

with 6 comments

blood414Blood has an interesting retraction of a 2011 paper on what a group of authors claimed was a new cell line — but which proved, apparently, to be a chimera.

The article, “Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC,” came from a team at Universität Duisburg-Essen, in Germany, and has been cited 21 times, according to Thomson Scientific’s Web of Knowledge. Here’s the abstract: Read the rest of this entry »

Blood retracts two red cell illustrations that “could have misled” readers

with 7 comments

blood cover214Blood has retracted two 2013 illustrations of red cells by researchers from South Africa and the United States because, somewhat confusingly, they didn’t conform to the journal’s criteria for publishing such material.

Here’s the notice for one of the images, “Red blood cell and platelet interactions in healthy females during early and late pregnancy, as well as postpartum”: Read the rest of this entry »

Retraction appears for stem cell researcher found to have used funds for his company’s gain

with 7 comments

Feuer_detail

Gerold Feuer in 2008, via Upstate

A stem cell journal is retracting a paper by Gerold Feuer, a researcher at the State University of New York (SUNY) Upstate Medical Center in Syracuse who was also found to have misused grants.

The Feuer story is complicated. Heralded in 2008 for landing $6.2 million in grants from the New York Stem Cell Board, Feuer was suspended in October 2010 while the university investigated allegations he had misused funds, specifically to funnel state dollars to HuMurine, a company he founded in 2008. In December 2010, Upstate said they had found evidence he had committed 53 acts of financial misconduct, and dismissed him.

From an August 2012 court ruling on a case Feuer brought to fight that dismissal: Read the rest of this entry »

Two Expressions of Concern in Blood for MD Anderson’s Aggarwal, who has threatened to sue Retraction Watch

with 34 comments

aggarwalBharat Aggarwal, the MD Anderson researcher who has threatened to sue us while under investigation by his institution for alleged misconduct, now has two Expressions of Concern in addition to two corrections and two unexplained withdrawals.

Both of the papers were published in Blood. The Expression of Concern for “Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway,” reads: Read the rest of this entry »

ORI rules in longstanding University of Washington misconduct case

with 13 comments

andrew_aprikyan

Andrew Aprikyan

A case of alleged misconduct at the University of Washington in Seattle may finally be over. The Office of Research Integrity released its findings following an investigation into the work of Andrew Aprikyan, a former hematology researcher at the university.

The Aprikyan case has dragged on for a decade. In 2010, the university fired the scientist after a court denied his appeals based on allegations that they had denied him due process. As the Seattle Times reported at the timeRead the rest of this entry »

Written by Ivan Oransky

April 8, 2013 at 1:38 pm

Follow

Get every new post delivered to your Inbox.

Join 35,047 other followers